企業プロフィール
Precipio Diagnostics 株価・ニュース・カタリスト
- ティッカー:
- PRPO
- 取引所:
- NASDAQ
- セクター:
- MedTech
- 所在地:
- United States
株価パフォーマンス
23.90 USD (+1.70%)
終値
最終更新: 2026年8月17日
40.2M USD
時価総額
株価変動の要因
The latest company update was “Precipio Announces Q2-2026 Financial Results”. PRPO changed 1.70% and closed at $23.90 on Aug 17, 2026, indicating a relatively limited closing-price reaction to this earnings update.
企業概要
Cancer Diagnostics Company
Precipio is a specialty cancer diagnostics company focused on reducing misdiagnosis in hematologic malignancies. It develops testing approaches intended to improve diagnostic accuracy for physicians, laboratories, and patients.
Integrated Clinical Laboratory
The company operates its own clinical laboratory, where it develops, validates, and uses diagnostic technologies in routine patient testing. This internal laboratory infrastructure provides a setting for generating clinical evidence and refining new assays before broader commercialization.
Products and Services Model
Precipio combines laboratory testing services with proprietary diagnostic products marketed to laboratories. This model allows the company to serve physicians directly while also distributing technologies that other laboratories can incorporate into their workflows.
今後のカタリスト
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。